FDA Adverse Event Malfunction Summary report: N

ALERE DETERMINE HIV 1/2 AG/AB COMBO

MDR report key: 7444353 · Received April 19, 2018

Report

Report Number
1221359-2018-00018
Event Type
Malfunction
Date Received
April 19, 2018
Date of Event
January 24, 2018
Report Date
April 19, 2018
Manufacturer
ALERE SCARBOROUGH INC.
Product Code
MZF
UDI-DI
07290015003735
PMA / PMN Number
BP120037-0
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TESTING WAS PERFORMED AT ALERE SCARBOROUGH ON RETAINED KIT LOT 170223 WITH THE FOLLOWING INTERNAL WHOLE BLOOD CONTROL SAMPLES: (B)(6), (B)(6), P24 POSITIVE, AND (B)(6). ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING BATCH RECORDS FOR LOT 170223 WERE REVIEWED. THIS LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED (B)(6) OR UNCONFIRMED (B)(6) RELATED TO LOT NUMBER 170223 SHOWED THAT THE COMPLAINT RATE IS (B)(4)%. THE EVIDENCE AVAILABLE DOES NOT INDICATE THAT THE PRODUCT IS PERFORMING OUTSIDE LABEL CLAIMS. ALERE SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE. THE RESULTS OBTAINED MAY POSSIBLY BE RELATED TO THE PATIENT SAMPLE. THE SAMPLE MAY HAVE CONTAINED SPECIFIC SUBSTANCES WHICH MAY HAVE AFFECTED THE RESULTS. THE AVAILABLE EVIDENCE SUGGESTS THAT THIS DEVICE LOT IS PERFORMING WITHIN LABELED CLAIMS.

Description of Event or Problem · 1

A FALSE POSITIVE AG RESULT WAS REPORTED ON A BLOOD SAMPLE TESTED WITH THE ALERE DETERMINE HIV 1/2 AG/AB COMBO. A QUANTITATIVE PCR TEST RESULT WAS RNA <20 COPIES/ML ((B)(6) FOR (B)(6)). THERE IS INSUFFICIENT INFORMATION TO DETERMINE IF A MALFUNCTION OCCURRED. THE PATIENT GENDER, PREGNANCY STATUS, TREATMENT AND PATIENT OUTCOME WERE UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
288284 ALERE DETERMINE HIV 1/2 AG/AB COMBO IVD FOR HIV AG/AB MZF ALERE SCARBOROUGH INC. 170223 07290015003735

Patients

Seq Age Sex Outcome Treatment
1